Review of computerised patient medication records to determine potential clinical interventions in community pharmacy

International Journal of Pharmacy Practice

Volumn 4, Issue 3, 1996, Pages 162-167

  Hannaoui, A ^a   Krass, I ^a   Benrimoj, S I ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Pharmacy Practice ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NITRATE; VASODILATOR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; COMPUTER ANALYSIS; DRUG CONTRAINDICATION; DRUG MONITORING; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MEDICAL RECORD; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; STATISTICAL ANALYSIS;

EID: 0029809566     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.1996.tb00860.x     Document Type: Article

References (37)

1. Graham D. Understanding the Pharmaceutical Benefits Scheme. Curr Ther 1994;35(11):11-4.
2. Caranassos G, Stewart R, Cluff I. Drug-induced illness leading to hospitalisation. JAMA 1974;228:713-7.
3. McKenney J, Harrison W. Drug-related hospital admissions. Am J Hosp Pharm 1993;NS33:61-70.
4. Cooper J, Campbell N, Frisk P. Community-hospital detection of drug related problems upon admission to small hospitals. Am J Hosp Pharm Ibid 1977;34:738-12.
5. Lamour I, Dolphin H, Baxter H, Morrison S, Hooke D, McGrath B. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991;21:90-5.
6. Jick H. Drugs remarkably non-toxic. New Engl J Med 1974;291:824-8.
7. Porter J, Jick H. Drug-related deaths among inpatients. JAMA 1977;237:879-81.
8. Lau N. Medication error analysis and intervention by a sole pharmacist. Aust J Hosp Pharm 1993;23:243-6.
9. Haslett T, Weissfellner B, Kay B. Documenting concurrent clinical pharmacy interventions. Hosp Pharm 1993;25:351-9.
10. Hassan Y, Aziz N, Awang J, Aminuldin A. An analysis of clinical pharmacist interventions in an intensive care unit. J Clin Pharm Ther 1992;17:317-51.
11. Bebee H, Freitag D. Documentation of clinical pharmacists' interventions: a two year review. Aust J Pharm 1990;20:356-60.
12. Hawkey C, Hodgson S, Norman A, Daneshmend T, Garner S. Effect of reactive pharmacy intervention on quality of hospital prescribing. Br Med J 1990;300:986-90.
13. Western Australian Clinical Pharmacists Group recording of pharmacist interventions: is there a better way? Aust J Hosp Pharm 1991;21:158-62.
14. Leversha A. An analysis of clinical pharmacist interventions and the role of clinical pharmacy at a regional hospital in Australia. Aust J Hosp Pharm Ibid 1991;21:222-8.
15. Orme J, Shafford A, Barber N, Schwartz B. Quality of hospital prescribing Br Med J 1990;300:1398.
16. Poston J, Shulman S. Patient medication records in community pharmacy. Pharm J 1985;234:412-3.
17. Ortiz M, Olsen W. The use of computers in community pharmacy. Aust J Pharm 1986;67:65-8.
18. Dwyer P, Kot T. Computerised drug-interaction programs: servants or masters of pharmacists? Aust J Pharm Ibid 1993;4:214-9.
19. Mant A, Whicker S, Kwok Y. Medication review: what your patients may not tell you. Aust Prescriber 1993;16:40-2.
20. Rogers P, Fletcher G, Rees JE. Clinical interventions by community pharmacists using patient medication records. Int J Pharm Pract 1994;3:6-13.
21. Dobie U, Rascati K. Documenting the value of pharmacist interventions. Am Pharm 1994;NS34:50-4.
22. Poston J, Kennedy R, Waruszynski M. Community pharmacist intervention study. Report for the Canadian Pharmaceutical Association, 1994.
23. Andrews A. Community pharmacists' cognitive services: interventions and their economic value that result from prescription-related problems in Washington State. Seattle: The Washington State Pharmacists Association, 1992.
24. Rupp M. Evaluation of prescribing errors and pharmacists' interventions in community practice: an estimate of value added. Am Pharm 1988;NS28:766-70.
25. Rupp M, Schondelmyer S, Wilson T, Krause J. Documenting prescribing errors and pharmacists' interventions in community practice. Med Care 1992;10:926-40.
26. Shimp L, Ascione F, Glazer H, Atwood B. Potential medication-related problems in non-institutionalised elderly. Drug Intell Clin Pharm 1985;19:766-72.
27. Brown G. Assessing the clinical impact of pharmacists' interventions. Am J Hosp Pharm 1991;48:2644-7.
28. Shane U, Saltiel E, White J, Flascha S. Using documentation of pharmacists' clinical activity. Am J Hosp Pharm Ibid 1991;48:2647-8.
29. USP DI. 13th ed. Taunton, Massachusetts: Rand McNally, 1993.
30. Facts and Comparisons. 3rd ed. St Louis, Missouri, Lippincott: 1992.
31. Australian Prescription Products Guide. Victoria: Australian Pharmaceutical Publishing Co Ltd, 1994.
32. Solomon D, Baumgartner P, Glascock L, Clascock S, Briscoe M, Billups N. Use of medication profiles to detect potential therapeutic problems in ambulatory patients. Am J Hosp Pharm 1974;31:348-54.
33. Larrat E, Taubman A, Willey C. Compliance-related problems in the ambulatory population. Am Pharm 1990;23:213-6.
34. Jepson H, Strickland-Hodge B. Patients' choice of pharmacy - the importance of patient medication records and patient registration. Pharm J 1993;251:R35.
35. Asher DM, Collett JH, Rees JA. Return of patients to community pharmacies for dispensing services. Pharm J Ibid 1993;251:R36.
36. Ruth D, Constable V, Daffey J, et al. General practitioners' and pharmacists' interprofessional communication. Aust Pharm 1994;13:431-3.
37. Lesar T, Briceland L, Delcoure K, Parmalee J, Masta-Gornic V, Pohl H. Medication prescribing errors in a teaching hospital. JAMA 1990;263:2329-34.